Work

Diversity, equity, and inclusion in genitourinary clinical trials leading to FDA novel drug approval: An assessment of the FDA center for drug evaluation and research drug trials snapshot

Year: 2023

Type: article

Source: Current Problems in Cancer

DOI: 10.1016/j.currproblcancer.2023.100958

Authors: Asia N. Matthew-Onabanjo, Gabrielle Nortey, Richard S. Matulewicz, Ramsankar Basak, Donna A. Culton, Kimberly N. Weaver, Kristalyn K. Gallagher, Hung-Jui Tan, Tracy L. Rose, Matthew Milowsky, Marc A. Bjurlin

Institutions: University of North Carolina at Chapel Hill, Memorial Sloan Kettering Cancer Center, UNC Lineberger Comprehensive Cancer Center, University of North Carolina Health Care

Language: English

Topic: Ethics in Clinical Research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: North Carolina Translational and Clinical Science Institute (NC TraCS), Selective histone deacetylase inhibition with entinostat to enhance the anti-tumor immune response to immune checkpoint inhibition in urothelial cancer, Cancer Center Support Grant

OpenAlex ID: W4365459067

FWCI: 0.51

Cites: 20

Cited by: 2

Related to: 10